167 related articles for article (PubMed ID: 17432227)
1. [Therapeutic strategies for muscular dystrophy by myostatin inhibition].
Sunada Y
Rinsho Shinkeigaku; 2006 Nov; 46(11):942-4. PubMed ID: 17432227
[TBL] [Abstract][Full Text] [Related]
2. Functional improvement of dystrophic muscle by myostatin blockade.
Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
[TBL] [Abstract][Full Text] [Related]
3. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
[TBL] [Abstract][Full Text] [Related]
4. Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.
Tsuchida K
Acta Myol; 2008 Jul; 27(1):14-8. PubMed ID: 19108572
[TBL] [Abstract][Full Text] [Related]
5. Myostatin propeptide-mediated amelioration of dystrophic pathophysiology.
Bogdanovich S; Perkins KJ; Krag TO; Whittemore LA; Khurana TS
FASEB J; 2005 Apr; 19(6):543-9. PubMed ID: 15791004
[TBL] [Abstract][Full Text] [Related]
6. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
[TBL] [Abstract][Full Text] [Related]
7. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
[TBL] [Abstract][Full Text] [Related]
8. Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C.
Bogdanovich S; McNally EM; Khurana TS
Muscle Nerve; 2008 Mar; 37(3):308-16. PubMed ID: 18041051
[TBL] [Abstract][Full Text] [Related]
9. A New Method of Myostatin Inhibition in Mice via Oral Administration of
Sung DK; Kim H; Park SE; Lee J; Kim JA; Park YC; Jeon HB; Chang JW; Lee J
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012334
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
Lamar KM; Bogdanovich S; Gardner BB; Gao QQ; Miller T; Earley JU; Hadhazy M; Vo AH; Wren L; Molkentin JD; McNally EM
PLoS Genet; 2016 May; 12(5):e1006019. PubMed ID: 27148972
[TBL] [Abstract][Full Text] [Related]
11. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
[TBL] [Abstract][Full Text] [Related]
12. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.
Ohsawa Y; Hagiwara H; Nakatani M; Yasue A; Moriyama K; Murakami T; Tsuchida K; Noji S; Sunada Y
J Clin Invest; 2006 Nov; 116(11):2924-34. PubMed ID: 17039257
[TBL] [Abstract][Full Text] [Related]
13. Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.
Morine KJ; Bish LT; Pendrak K; Sleeper MM; Barton ER; Sweeney HL
PLoS One; 2010 Feb; 5(2):e9176. PubMed ID: 20161803
[TBL] [Abstract][Full Text] [Related]
14. [Anti-myostatin antibody therapy for myopathies].
Sunada Y
Rinsho Shinkeigaku; 2011 Nov; 51(11):1157-9. PubMed ID: 22277518
[TBL] [Abstract][Full Text] [Related]
15. Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.
Puolakkainen T; Ma H; Kainulainen H; Pasternack A; Rantalainen T; Ritvos O; Heikinheimo K; Hulmi JJ; Kiviranta R
BMC Musculoskelet Disord; 2017 Jan; 18(1):20. PubMed ID: 28103859
[TBL] [Abstract][Full Text] [Related]
16. [Myostatin blockade therapy for muscular atrophy].
Sunada Y
Brain Nerve; 2011 Nov; 63(11):1271-7. PubMed ID: 22068480
[TBL] [Abstract][Full Text] [Related]
17. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
18. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.
Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Wang J; Fan Z; Liu N; Warsing LC; Grange RW; Ahn M; Balog-Alvarez CJ; Cotten SW; Willis MS; Brinkmeyer-Langford C; Zhu H; Palandra J; Morris CA; Styner MA; Wagner KR
Skelet Muscle; 2016; 6():14. PubMed ID: 27047655
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice.
Benabdallah BF; Bouchentouf M; Rousseau J; Bigey P; Michaud A; Chapdelaine P; Scherman D; Tremblay JP
Cell Transplant; 2008; 17(3):337-50. PubMed ID: 18522236
[TBL] [Abstract][Full Text] [Related]
20. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice.
Wagner KR; McPherron AC; Winik N; Lee SJ
Ann Neurol; 2002 Dec; 52(6):832-6. PubMed ID: 12447939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
